Diffuse intrinsic pontine gliomas (DIPG) at recurrence: is there a window to test new therapies in some patients?

Janssens, Geert O; Kramm, Christof M; Von Bueren, André

doi:10.1007/s11060-018-2871-z

Scientific article

Letter

English

Diffuse intrinsic pontine gliomas (DIPG) at recurrence: is there a window to test new therapies in some patients?

ContributorsJanssens, Geert O; Kramm, Christof M; Von Bueren, André

Published inJournal of Neuro-Oncology, vol. 139, no. 2, 501

Publication date2018

Keywords

Brain Stem Neoplasms/pathology/radiotherapy
Glioma/pathology/radiotherapy
Humans
Neoplasm Recurrence
Local/diagnosis/mortality/pathology
Prognosis
Radiotherapy/mortality
Survival Rate

Affiliation entities

Faculté de médecine / Section de médecine clinique / Département de pédiatrie, gynécologie et obstétrique

Research groups

Oncologie et hématologie pédiatrique (907)

Citation (ISO format)

JANSSENS, Geert O, KRAMM, Christof M, VON BUEREN, André. Diffuse intrinsic pontine gliomas (DIPG) at recurrence: is there a window to test new therapies in some patients? In: Journal of Neuro-Oncology, 2018, vol. 139, n° 2, p. 501. doi: 10.1007/s11060-018-2871-z

Article (Published version)

Identifiers

PID : unige:128632
DOI : 10.1007/s11060-018-2871-z
PMID : 29667083

Additional URL for this publicationhttps://link.springer.com/article/10.1007%2Fs11060-018-2871-z

Journal ISSN0167-594X

262views

103downloads

Creation06/11/2019 10:59:00

First validation06/11/2019 10:59:00

Update time15/03/2023 18:41:50

Status update15/03/2023 18:41:49

Last indexation31/10/2024 17:30:49

Archive ouverte UNIGE

Diffuse intrinsic pontine gliomas (DIPG) at recurrence: is there a window to test new therapies in some patients?

Technical informations